Cost of poor adherence to anti-hypertensive therapy in five European countries

The financial burden for EU health systems associated with cardiovascular disease (CV) has been estimated to be nearly €110 billion in 2006, corresponding to 10 % of total healthcare expenditure across EU or a mean €223 annual cost per capita. The main purpose of this study is to estimate the costs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European journal of health economics 2015-01, Vol.16 (1), p.65-72
Hauptverfasser:	Mennini, F. S., Marcellusi, A., von der Schulenburg, J. M. Graf, Gray, A., Levy, P., Sciattella, P., Soro, M., Staffiero, G., Zeidler, J., Maggioni, A., Schmieder, R. E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antihypertensive Agents - administration & dosage Antihypertensive Agents - therapeutic use Antihypertensives Blood Pressure Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - economics Cost control Decision Trees Demography Economic impact Economic Policy Economics Europe - epidemiology Female Health care expenditures Health Care Management Health care policy Health Economics Health Expenditures - statistics & numerical data Heart Humans Hypertension Hypertension - drug therapy Hypertension - economics Hypertension - epidemiology Male Manycountries Medication Adherence - statistics & numerical data Medicine Medicine & Public Health Middle Aged Monte Carlo Method Original Paper Patients Pharmacoeconomics and Health Outcomes Prevalence Public Finance Public Health Quantitative Finance Sensitivity analysis State Medicine - statistics & numerical data Statistical analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!